(Q24201979)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

0 references

0 references

0 references

chronic neuropathic pain

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

2

Sheena Derry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

3

R Andrew Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

publication date

3 December 2013

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

page(s)

CD006044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine in spinal cord injury pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for central poststroke pain: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine reduces total postoperative analgesic requirement: a randomized double-blind, placebo-controlled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine in the treatment of chronic refractory neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The use of lamotrigine in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine in the treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for intractable sciatica: correlation between dose, plasma concentration and analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine monotherapy for control of neuralgia after nerve section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Pain and the brain: specificity and plasticity of the brain in clinical chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Phenytoin for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Clonazepam for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Topical capsaicin (low concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Topical capsaicin (high concentration) for chronic neuropathic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Anticonvulsants in central pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lacosamide for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Predictors of Lamotrigine-associated rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Anticonvulsants in neuropathic pain: rationale and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Epidemiology and Clinical Features of Idiopathic Trigeminal Neuralgia and Glossopharyngeal Neuralgia: Similarities and Differences, Rochester, Minnesota, 1945-1984

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Topical lidocaine for the treatment of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Incidence of facial pain in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Fibromyalgia and neuropathic pain--differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Duloxetine for treating painful neuropathy or chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine in the management of neuropathic pain: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Brain imaging of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Chronic low back pain analgesic studies--a methodological minefield

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Gabapentin for chronic neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Amitriptyline for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Neuropathic features of joint pain: a community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Can neuroimaging studies identify pain endophenotypes in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Carbamazepine for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Antiepileptic drugs for neuropathic pain and fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Topiramate for neuropathic pain and fibromyalgia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

A new definition of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006044.PUB4

Response of thalamic pain syndrome to lamotrigine

21 January 2018

1 reference

12 December 2020

The epidemiology of self-reported fibromyalgia in Canada.

1 reference

12 December 2020

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

1 reference

12 December 2020

Patient-centered perspective on treatment outcomes in chronic pain

1 reference

12 December 2020

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

1 reference

12 December 2020

The number needed to treat: a clinically useful measure of treatment effect

1 reference

12 December 2020

The importance of quality of primary studies in producing unbiased systematic reviews

1 reference

12 December 2020

10.1002/14651858.CD006044.PUB4

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3883078

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

OpenCitations bibliographic resource ID

14 May 2020

3883078

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6485508&resulttype=core&format=json

14 May 2020

1 reference